← Back to Patent Explorer
US4329427A Expired / Lapsed US ⏱️ 0.0 years remaining

Fermentative preparation of L-isoleucine

Assignee: WR Grace and Co
•
Filing: 1980-10-06
•
Granted: 1982-05-11
•
Expires: 2000-10-06
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract L-isoleucine is prepared by cultivation of an analogue-resistant mutant of Brevibacterium thiogenitalis in an aqueous nutrient medium under aerobic conditions in the presence of from 0.001 to 15 w/v percent of a post-threonine precursor for L-isoleucine. The cultivation is preferably carried out at about 30° C. and at a pH of 5 to 9. L-isoleucine is recovered from the fermentation broth.

Inventors

  • 👤 Mark H. Updike
  • 👤 Gary J. Calton

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 20:39
CPC Classifications
C; C12; C12P; C12P13/00; C12P13/04; C12P13/06; C12N; C12N1/00; C12N1/20; C12N1/205; C12R; C12R2001/00; C12R2001/01; C12R2001/13; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/822; Y10S435/84

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 105 words
A process for preparing L-isoleucine which comprises cultivating under aerobic conditions a mutant strain of Brevibacterium thiogenitalis resistant to an analogue of L-isoleucine selected from the group consisting of α-amino-β-hydroxyvaleric acid; methylglycine; gammadehydroisoleucine; 3-cyclopentene-1-glycine; 2-cyclopentene-1-glycine; o-methylthreonine; and β-hydroxyleucine, said cultivation carried out in the presence of a post-threonine biosynthetic precursor of L-isoleucine selected from the group consisting of α-hydroxy butyric acid, α-aceto-α-hydroxy butyric acid, α,β-dihydroxy-β-methylvaleric acid, α-keto butyric acid, and D,L-α-amino-n-butyric acid and alkali metal salts thereof, to yield a fermentation broth, accumulating from about 0.1 to about 6 w/v percent L-isoleucine in said fermentation broth, and recovering the accumulated L-isoleucine from said fermentation broth.
Claim 2
Dependent Claim 105 words
A process for preparing L-isoleucine which comprises cultivating under aerobic conditions a mutant strain of Brevibacterium thiogenitalis resistant to an analogue of L-isoleucine selected from the group consisting of α-amino-β-hydroxyvaleric acid; methylglycine; gammadehydroisoleucine; 3-cyclopentene-1-glycine; 2-cyclopentene-1-glycine; o-methylthreonine; and β-hydroxyleucine, said cultivation carried out in the presence of a post-threonine biosynthetic precursor of L-isoleucine selected from the group consisting of α-hydroxy butyric acid, α-aceto-α-hydroxy butyric acid, α,β-dihydroxy-β-methylvaleric acid, α-keto butyric acid, and D,L-α-amino-n-butyric acid and alkali metal salts thereof, to yield a fermentation broth, accumulating from about 0.1 to about 6 w/v percent L-isoleucine in said fermentation broth, and recovering the accumulated L-isoleucine from said fermentation broth.
Claim 3
Dependent Claim 14 words
A process as in claim 1 wherein the mutant is Brevibacterium thiogenitalis ATCC 31723.
Claim 4
Dependent Claim 24 words
A process as in claim 1 wherein the concentration of precursor in the media prior to fermentation is from 0.001 to 15 w/v percent.
Claim 5
Dependent Claim 27 words
A process as in claim 1 wherein the fermentation is carried out at a temperature of from 20° to 45° C. for from 8 to 176 hours.
Claim 6
Dependent Claim 20 words
A process as in claim 1 wherein the pH of the fermentation media during cultivation is from 5 to 9.
Claim 7
Dependent Claim 38 words
A process as in claim 1 wherein the mutant is Brevibacterium thiogenitalis ATCC 31723 and fermentation is carried out at from 20° to 45° C. for 8 to 176 hours at a pH of from 5 to 9.
Claim 8
Dependent Claim 19 words
A process as in claim 1 wherein the precursor is α-keto butyric acid or an alkali metal salt thereof.
Claim 9
Dependent Claim 18 words
A process as in claim 1 wherein the precursor is D,L-α-amino-n-butyric acid or an alkali metal salt thereof.
Claim 10
Dependent Claim 13 words
A process as in claim 1 wherein the analogue is α-amino-β-hydroxy valeric acid.

References Cited (Backward Citations)

US4237228A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-05-10 1985-11-09 1986-05-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-05-10 1989-11-09 1990-05-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-05-10 1993-11-09 1994-05-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag